Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Participants With Traumatic Brain Injury

ClinicalTrials.gov ID: NCT03095066

Public ClinicalTrials.gov record NCT03095066. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 11:49 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Patients With Traumatic Brain Injury (TBI).

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multicenter, randomized, placebo-controlled study to evaluate AVP-786 for the treatment of neurobehavioral disinhibition including aggression, agitation, and irritability in participants with traumatic brain injury (TBI).

Study identification

NCT ID
NCT03095066
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
168 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 30, 2017 (Actual)
Primary completion
Aug 22, 2022 (Actual)
Completion
Aug 31, 2022 (Actual)
Last update posted
Oct 29, 2025

2017 – 2022

United States locations

U.S. sites
54
U.S. states
21
U.S. cities
48
Facility City State ZIP Site status
Tuscaloosa Veterans Affairs Medical Center Tuscaloosa Alabama 35404 —
Absolute Clinical Research Site#207 Phoenix Arizona 85051 —
Perseverance Research Center Site#152 Scottsdale Arizona 85254 —
ATP Clinical Research Site#150 Costa Mesa California 92626 —
Kaizen Brain Center #224 La Jolla California 92037 —
Sunwise Clinical Research, LLC Site#216 Lafayette California 94543 —
Torrance Clinical Research Institute Site#157 Lomita California 90717 —
Tibor Rubin VA Medical Center, SCIRE Biomedical Research Institute Long Beach California 90822 —
Asclepes Research Centers - Panorama City Site #208 Panorama City California 91402 —
The Neurology Group Pomona California 91767 —
Mountain Mind Colorado Springs Colorado 80903 —
Mountain View Clinical Research, Inc. Site# 202 Denver Colorado 80209 —
Medical Center of the Rockies Loveland Colorado 80538 —
Connecticut Clinical Research Cromwell Connecticut 06416 —
Bradenton Research Center, Inc Bradenton Florida 34205 —
Healthcare Innovative Institute, LLC Site# 173 Coral Springs Florida 33067 —
Science Connections, LLC Site#161 Doral Florida 33166 —
Design Neuroscience Center, PL Doral Florida 33172 —
Alphab Global Research Site#163 Jupiter Florida 33458 —
Meridien Research Maitland Florida 32751 —
Premier Clinical Research Institute, Inc. Miami Florida 33122 —
Project 4 Research Miami Florida 33125 —
Allied Biomedical Research Institute, Inc. Site#151 Miami Florida 33155 —
Health Synergy Clinical Research Okeechobee Florida 34972 —
Roskamp Institute Clinic, Inc. Sarasota Florida 34243 —
USF Dept of Psychiatry and Behavioral Neurosciences Site# 214 Tampa Florida 33613 —
Meridien Research Site# 108 Tampa Florida 33634 —
Hawaii Pacific Neuroscience Site#184 Honolulu Hawaii 96817 —
The University of Kentucky research foundation Lexington Kentucky 40536 —
Baptist Health Richmond Kentucky 40475 —
Sisu BHR Site#200 Springfield Massachusetts 01103 —
Neurobehavioral Medicine Group #222 Bloomfield Hills Michigan 48302 —
Millennium Psychiatric Associates, LLC Creve Coeur Missouri 63141 —
Sharlin Health and Neurology Ozark Missouri 65721 —
Clinical Research Professionals St Louis Missouri 63141 —
JFK Johnson Rehabilitation Institute Edison New Jersey 08820 —
The NeuroCognitive Insititute Mount Arlington New Jersey 07856 —
New York University School of Medicine Site #122 New York New York 10016 —
Atrium Health - Carolinas Rehabilitation - Charlotte Site #166 Charlotte North Carolina 28203 —
New Hope Clinical Research Site#194 Charlotte North Carolina 28211 —
Carolina Headache Institute Durham North Carolina 27713 —
Salisbury VAMC Salisbury North Carolina 28144 —
Valley Medical Research Centerville Ohio 45459 —
Cincinnati VA Medical Center Cincinnati Ohio 45220 —
North Star Medical Research, LLC Site#154 Middleburg Heights Ohio 44130 —
IPS Research Site#196 Oklahoma City Oklahoma 73106 —
University of Pittsburgh Pittsburgh Pennsylvania 15213 —
WJB Dorn VA-Wm. Jennings Bryan Dorn VA Medical Center Columbia South Carolina 29205 —
University of Texas Southwestern Medical Site#140 Dallas Texas 75390 —
Polytrauma Rehabilitation Center S. Texas VA Health Care System Site# 146 San Antonio Texas 78229 —
Cedar Clinical Research #221 Draper Utah 84020 —
Virginia Commonwealth University #172 Richmond Virginia 23298 —
Virginia Commonwealth University Site#172 Richmond Virginia 23298 —
Salem Research Institute Site# 138 Salem Virginia 24153 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03095066, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 29, 2025 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03095066 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →